115 related articles for article (PubMed ID: 8815424)
1. Supervised intradialytic oral iron administration during erythropoietin therapy.
Fourtounas C; Koutsikos D; Dalamangas A; Kapetanaki A; Kostoglou M; Agroyannis B; Tzanatos H; Kopelias I; Bosiolis B
Nephrol Dial Transplant; 1996 Jul; 11(7):1485-6. PubMed ID: 8815424
[No Abstract] [Full Text] [Related]
2. Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.
Kotaki M; Uday K; Henriquez M; Blum S; Dave M
Clin Nephrol; 1997 Jul; 48(1):63-4. PubMed ID: 9247787
[No Abstract] [Full Text] [Related]
3. Comparison of oral versus intravenous iron therapy in predialysis patients of chronic renal failure receiving recombinant human erythropoietin.
Aggarwal HK; Nand N; Singh S; Singh M; Hemant ; Kaushik G
J Assoc Physicians India; 2003 Feb; 51():170-4. PubMed ID: 12725261
[TBL] [Abstract][Full Text] [Related]
4. Minor impairment of oral iron absorption in non-diabetic new dialysis patients.
Tovbin D; Schnaider A; Vorobiov M; Rogachev B; Basok A; Shull P; Novack V; Friger M; Avramov D; Zlotnik M
J Nephrol; 2005; 18(2):174-80. PubMed ID: 15931645
[TBL] [Abstract][Full Text] [Related]
5. Resistance to recombinant human erythropoietin treatment in thalassaemic patients on chronic haemodialysis: a real clinical entity?
Tarng DC; Huang TP; Chen TW; Fan CY; Chang JG
Nephrol Dial Transplant; 1996 Sep; 11(9):1893-5. PubMed ID: 8918654
[No Abstract] [Full Text] [Related]
6. [Treatment with low doses of intravenous iron does not modify hemoglobin nor the erythropoietin dosage].
Fernández-Gallego J; Martín MA; Alonso A; Toledo R
Nefrologia; 2006; 26(1):143-4. PubMed ID: 16649439
[No Abstract] [Full Text] [Related]
7. An evaluation of the effectiveness of oral iron therapy in hemodialysis patients receiving recombinant human erythropoietin.
Markowitz GS; Kahn GA; Feingold RE; Coco M; Lynn RI
Clin Nephrol; 1997 Jul; 48(1):34-40. PubMed ID: 9247776
[TBL] [Abstract][Full Text] [Related]
8. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
El-Khatib M; Duncan HJ; Kant KS
Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
[TBL] [Abstract][Full Text] [Related]
9. [Effect of deferoxamine on erythropoiesis in patients hemodialyzed for chronic renal insufficiency treated with erythropoietin].
Kalinowski M; Popławski A; Kaliszewski Z; Juzwiuk J
Pol Merkur Lekarski; 1996 Oct; 1(4):232-4. PubMed ID: 9156931
[TBL] [Abstract][Full Text] [Related]
10. Effects of erythropoietin therapy on iron absorption in chronic renal failure.
Skikne BS; Ahluwalia N; Fergusson B; Chonko A; Cook JD
J Lab Clin Med; 2000 Jun; 135(6):452-8. PubMed ID: 10850644
[TBL] [Abstract][Full Text] [Related]
11. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of erythropoiesis on supervised intradialytic oral iron and vitamin C therapy is correlated with Kt/V and patient weight.
Tovbin D; Markowitz A; Mostoslavsky M; Landver R
Clin Nephrol; 2000 Apr; 53(4):276-82. PubMed ID: 10809415
[TBL] [Abstract][Full Text] [Related]
13. Lessons from NKF-DOQI: iron management.
Van Wyck DB
Semin Nephrol; 2000 Jul; 20(4):330-4. PubMed ID: 10928334
[No Abstract] [Full Text] [Related]
14. [Treatment of anemia in chronically dialyzed patients].
Moynot A
Nephrologie; 1998; 19(3):125-7. PubMed ID: 9633055
[No Abstract] [Full Text] [Related]
15. Effectiveness of oral and intravenous iron therapy in haemodialysis patients.
Jenq CC; Tian YC; Wu HH; Hsu PY; Huang JY; Chen YC; Fang JT; Yang CW
Int J Clin Pract; 2008 Mar; 62(3):416-22. PubMed ID: 17511797
[TBL] [Abstract][Full Text] [Related]
16. The use of IV iron in the treatment of anaemia of ESRD patients on maintenance haemodialysis: an historical and personal view.
Shaldon S
Nephrol Dial Transplant; 2007 Jan; 22(1):23-5. PubMed ID: 17088269
[No Abstract] [Full Text] [Related]
17. Adjusting i.v. iron and EPO doses in patients on hemodialysis prior to continuing surgery: can we protect our patients education from iron-deficiency anemia?
Deaver K; Bennington L
Nephrol Nurs J; 2006; 33(4):430-7; quiz 438. PubMed ID: 17002001
[TBL] [Abstract][Full Text] [Related]
18. [Periodic hemodialysis, anemia and iron deficiency. Etiopathogenic diagnosis and therapeutic aspects].
Escribano Mora L; Sanz Guajardo A
Rev Clin Esp; 1978 May; 149(3):217-21. PubMed ID: 694091
[No Abstract] [Full Text] [Related]
19. Iron supplementation in renal anemia.
Fishbane S
Semin Nephrol; 2006 Jul; 26(4):319-24. PubMed ID: 16949471
[TBL] [Abstract][Full Text] [Related]
20. [Anemia in chronic hemodialysis; comparative value of iron therapy administered by oral and intravenous routes].
Ducros J; Benas P; Salvadori JM; Olmer M
J Urol Nephrol (Paris); 1977 Sep; 83(9):735-8. PubMed ID: 926237
[No Abstract] [Full Text] [Related]
[Next] [New Search]
